T cells produce an antigen-binding factor with in vivo activity analogous to IgE antibody by unknown
T  CELLS  PRODUCE  AN  ANTIGEN-BINDING  FACTOR  WITH 
IN VIVO  ACTIVITY  ANALOGOUS  TO  IgE  ANTIBODY* 
By P.  W.  ASKENASE,:~  R.  W.  ROSENSTEIN, AND W.  PTAK 
From the Departments of Medicine and Pathology and the Howard Hughes Medical Institute,  Yale 
University School of Medicine, New Haven, Connecticut 06510," and the Department of hnmunology, 
Copernicus Medical School, Cracow, Poland 
Delayed-type hypersensitivity skin reactions are  mediated by recirculating, sensi- 
tized Ly-I  ÷ T  cells (1,  2)  that enter the tissues and are activated by specific antigen. 
This leads to the release of various nonspecific macromolecular mediators (lympho- 
kines) that attract various leukocytes to leave the circulation and enter the tissues to 
comprise  a  characteristic  infiltrate  of  inflammatory  cells.  In  mice,  this  cellular 
recruitment requires that the activated T  cells also activate resident tissue mast cells 
to release the vasoactive amine serotonin, which causes gaps to form between vascular 
endothelial cells (3  6). This allows the leukocytes to emigrate into the extravascular 
tissue spaces in response to chemattractant lymphokines (5, 6). 
The fact that T  cell-dependent activation of mast cells is required for elicitation of 
delayed-type hypersensitivity led  us  to  investigate whether  a  T  cell  product  could 
mimic some of the functions of immunoglobulin  E  (IgE) antibody. We have described 
(7) a T  cell-derived antigen-binding  factor that transfers an immediate hypersensitiv- 
ity-like  reaction.  In  the  present  study  this  T  cell  factor  was  compared  with  a 
hybridoma |gE antibody. Both transferred sensitization for elicitation of immediate- 
type skin reactions with accompanying vascular permeability. Neither was active in 
mast cell-deficient mice. The T  cell factor was distinguished from IgE by a  number 
of immunochemical and  biological  properties;  including affinity chromatography 
using specific anti-IgE and anti-factor antibodies, and a  shorter duration of passive 
sensitization.  The  T  cell  factor  is  a  suitable  candidate  for  participation  in  the 
mechanism by which T  cells activate mast cells in delayed-type hypersensitivity. 
Materials and Methods 
Mice.  Male CBA/J  and  two  types of mast  cell-deficient mice,  [WBB6F1  (WB-W/+  × 
C57BI6-WV/+)-W/W  v  and  their  normal  litter  mates  (WBB6Fr+/+),  and  WCB6F1 
(WC-SI/+ x  C57BI/6-sId/+)-SI/S1  d and their normal litter mates  (WCB6FI -  +/+)]  were 
obtained from The Jackson Laboratory, Bar Harbor, ME and were rested at least  1 wk in an 
air-filtered enclosure before use. 
Reagents.  Picryl chloride (PCL) 1 (Chemotronix Inc., Swannonoa, NC)  recrystalized three 
times from methanol/H20 before use, and oxazolone (OX) (Gallard-Schesinger  Chemical Mfg. 
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Corp., Carle Place, NY), recrystalized three times from ethanol, were protected from light in a 
dessicator during storage at 25°C. Bovine gamma globulin (BGG) and epsilon-amino caproic 
acid (EACA) were purchased from Sigma Chemical Co., St. Louis, MO. Ascites fluid containing 
2 mg/ml of murine monoclonal anti-2, 4-dinitrophenyl (DNP) IgE antibody (H1  DNP-e-26), 
hapten affinity-purified monoclonal anti-DNP IgE antibody prepared from this ascites,  and 
monospecific rabbit anti-IgE made with this monoclonal IgE were gifts  from Dr.  David H. 
Katz and Dr. Fu-Tong Liu, Dept. of Immunology, Medical Biology Institute, La Jolla, CA (8). 
Another anti-DNP monoclonal IgE (SPE-7-IF, both in ascites fluid and hapten affinity purified) 
was  provided by  Dr.  Zelig Eschar,  Weizmann Institute, Rehovot,  Israel  (9). Ascites  fluid 
containing anti-ovalbumin  monoclonal IgE was provided by Dr. Irmgard B6ttcher (10). 
General Methods.  Affinity chromatography was performed at 4°C with Sepharose 4B (Phar- 
macia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N  J) as the support matrix. Proteins 
were covalently attached to sepharose by the cyanogen bromide technique (11). 2,4,6-trinitro- 
phenyl (TNP)  was covalently attached  to  BGG-Sepharose by reaction with trinitrobenzene 
sulfonic acid (Eastman Laboratory and Specialty Chemicals, Eastman Kodak Co., Rochester, 
NY) in 0.2 M Na2 CO3 at pH 11. A ratio of 10 mg of trinitrobenzene  sulfonic acid for each 10 
mg of BGG was used. OX coupling to BGG was performed by reacting OX dissolved in ethanol 
with BGG sepharose so that 10% of the reaction mixture was ethanol in 0.2 M Na2 COs at pH 
11. TNP-EACA was prepared by reaction of trinitrobenzene  sulfonic acid with EACA in 0.2 M 
Na2 CO3 at pH  11. TNP-EACA was extracted from the acidified (pH _< 2.5) reaction mixture 
with ethyl acetate and crystalized from methyl alcohol/H20. 
Contact Sensitization and Production of Specific Antigen-binding Factors  from Lymphoid Cells of Contact- 
sensitized Mice.  Donor CBA/J male mice (8-10 wk old) were sensitized by topical application 
of either 0.15 ml of 5% PCL or 3% OX in absolute ethanol and acetone (3:1) to the shaved 
abdomen, chest, and four feet. 4 d later spleen and peripheral lymph node cells from these mice 
(~1-2 ×  108 cells/mouse) were cultured in vertical 250-ml flasks (70-150 ml/flask) at 1.5 X 10  v 
cells/ml in serum-free RPMI 1640 medium (Gibco Laboratories, Grand Island Biological  Co., 
Grand Island, NY) supplemented with mycostatin, gentamycin, and streptomycin, for 48 h at 
37°C  in  5%  CO2.  The  culture  fluid  supernatant  was  then  separated  from  the  cells  by 
centrifugation for 7 min at 25°C at 2,500 rpm in an HG 4L rotor (DuPont Instruments-Sorvall 
Biomedical Div., Wilmington, DE) and antigen-binding  material (hereafter called PCL factor, 
PCLF, or OX factor, OXF) was purified by addition of the culture fluids (100-200 ml) to an 
affinity matrix composed respectively of TNP-BGG-tinked  Sepharose beads or OX-BGG-linked 
Sepharose beads, followed  by overnight incubation of the mixture at 4°C with gentle stirring. 
The mixtures were then poured into columns over a  bed of G25 Sephadex  (Pharmacia Fine 
Chemicals), and washed with 5 column vol  of phosphate-buffered saline (PBS).  The TNP- 
BGG-Sepharose columns that bound material from supernatants of cells from mice sensitized 
with  PCL  were  then eluted at  4°C  with 0.05  M  TNP-EACA. In some experiments, 5  M 
guanidine was  also  used for elution. The OX-BGG Sepharose columns that bound material 
from supernatants of cells from mice sensitized with OX were eluted with 5 M guanidine. The 
respective eluates, in a  volume of ~5-10% of the original supernatants, were then dialyzed 
exhaustively at 4°C against PBS. Finally, PCLF and OXF were dialyzed into 0.15 M NaCI for 
intravenous transfer. The protein content of purified PCLF ranged from 0.1-0.3 mg/ml for the 
12 preparations used in this study, as measured by the method of Bradford (12). In a typical 
experiment supernatant obtained from lymphoid cells of 50-100 PLC-sensitized mice resulted 
in  2-rag  yield  of  hapten  affinity-purified PCLF  protein,  and  supernatant obtained  from 
lymphoid cells of 30 OX-sensitized mice resulted in 2.4-mg yield of hapten affinity-purified 
OXF protein. 
Bioassay of PCLF or OXF.  Unless otherwise stated, 75 pg PCLF or OXF in 0.5 ml 0.15 M 
NaCI was injected intravenously  via the retro-orbital plexus into lightly ether-anesthesized mice 
and both sides of their ears were challenged immediately thereafter by topical application of a 
drop (27-gauge needle) of 0.8% PCL or 0.8% OX in olive oil.  Duplicate measurement of ear 
thickness was made with an engineer's micrometer (Mitutoyo, Tokyo, Japan) before challenge 
and at various times from 0.5-24 h later. The increment in ear thickness was expressed  as the 
mean "I-- SE  in units of  10  -3 cm  (13). In each  experiment the ears of a  separate group of 864  T CELL-PRODUCED ANTIGEN-BINDING FACTOR ANALOGOUS TO  IgE 
noninjected controls were challenged and measured similarly to mice that received either PCLF 
or OXF. 
Direct Binding Enzyme-linked Immunosorbent Assay  (ELISA) for  Various Antigenic Determinants in 
PCLF or OXF.  Each of the 12 different preparations of PCLF used in this study, a preparation 
of OXF,  and  mouse  Ig  standards  were  coated  onto  the  wells  of  plastic  microtrays  at  a 
concentration of 100 ng/well. As described previously (7),  none of the PCLF preparations,  nor 
the OXF preparation,  had Ig antigenic determinants  detected by anti-x, -~, -/~, -a, -7, -6, or -E 
antisera,  while all factor preparations  had  antigenic determinants  detected by three different 
rabbit  anlisera prepared against antigen-specific T  cell factors from other systems  (7,  14-16). 
Production of Rabbit Antz'-factor Antisera.  Antfsera  were produced  in  colIaboratio~  with  Dr. 
Robert  Cone  (Dept.  of Pathology,  Yale  University School  of Medicine,  New  Haven,  CT) 
according to the method used to produce rabbit  anti-T cell derived suppressor  factor (14,  15, 
17).  Rabbits  were injected with 200 #g PCLF emulsified in complete Freund's  adjuvant  and 
were boosted with PCLF and poly AU (14,  15). Antisera obtained were routinely screened for 
anti-mouse  Ig  heavy  and/or  light  chain  isotypes  and  anti-hapten  activity by  ELISA.  Anti- 
PCLF sera used were negative for binding to Ig determinants, but always contained anti-TNP 
activity.  This  anti-TNP  activity  was  absorbed  out  by  passage  over  TNP-BGG  Sepharose 
absorbents,  and this absorbtion  was confirmed by ELISA using TNP-BGG-coated plates. 
Competitive Binding Radioimmunoassay oflgE.  A  modified solid-phase radioimmunoassay  was 
used  (18).  The  18% NazSO4 globulin fraction of rabbit  anti-IgE (1:1,000 dilution)  was coated 
onto polystyrene flat-bottomed nonsterile microtrays (Linbro Scientific, Hamden, CT). Hapten 
affinity purified monoclonal IgE (H 1 DNP-e-26) was iodinated with lzsI by the lactoperoxidase 
method (19).  About  15 ng of t25I-IgE (75,000 cpm) in PBS containing 0.05% triton-X 100 (New 
England  Nuclear, Boston, MA) were mixed with various concentration of either two different 
preparations  of PCLF,  two different  anti-DNP  hybridoma  IgE antibodies or anti-ovalbumin 
hybridoma lgE antibody, and then, were added to the anti-IgE-coated wells and incubated at 
20°C temperature for 12 h after which the wells (in duplicate) were washed, dried, excised, and 
placed in tubes for counting in a  gamma counter. The results were expressed as the percent of 
lZSl-IgE counts added  per well that bound to the well surface. 
Affinity  Chromatography with Anti-IgE vs. Anti-PCLF Sepharose.  An  18% Na2SO4 precipitate of 
rabbit  anti-IgE  and  rabbit  anti-PCLF  sera  was  prepared,  and  the  globulin  fractions  were 
resotubilized  and  con iugated  separately  to Sepharose  via cyanogen  bromide  (11).  Duplicate 
1.0-mt columns of each  type were prepared,  and  [gE  (H l  DNP-e-26 ascites)  and  PCLF were 
applied  to each column  at: 4°C.  The  material  passing  through  the column  (the filtrate)  was 
collected and the columns were washed with PBS and then eluted with 0.2 M  NazCOa (pH  11). 
The  resulting eluate  was  dialyzed against  PBS and  then  against  saline.  The fihrate  and  the 
eluate from  each column were then  transferred  intravenously  to normal  recipients that  were 
challenged immediately thereafter by ear painting with 0.8% PCL in olive oil. 
Assay of Increased Vascular Permeability.  Bovine serum albumin was iodinated with 125I by the 
lactoperoxidase  method  (18).  Iodinated  albumin  was  mixed  with  PCLF  or  IgE  that  were 
transferred intravenously to separate groups of mice that were then challenged immediately by 
painting their ears with 0.8% PCL. 4 h  later, after ear thickness measurements were repeated, 
the animals (and controls that just received azSI-albumin before PCL challenge) were killed and 
their ears were excised and placed in tubes for counting in a  gamma counter. 
AJfini~ Chromatography of Polyclonal IgE Antibody Activity Determined  by Passive Cutaneous Anaphylaxis 
(PCA)  Titration.  Sera  containing  polyclonal  IgE  antibody  from  BALB/c  mice  that  were 
primed and boosted multiple times with DNP conjugated ascaris antigen were provided by Dr. 
David  H.  Katz.  PCA  titratious  were  performed  by  making  an  initial  1:50  dilution  and 
subsequent  twofold  dilutions  in  Locke's  buffer  containing  0.1%  bovine serum  albumin  and 
injecting 50 #1 of the various dilutions into the flank skin of three Sprague Dawley rats (150 g). 
2 h  later,  1 mg of DNP-albumin  was injected intravenously with  1% Evan's blue dye, and  30 
rain later the animals were killed and the last dilution resulting in a  blue spot of extravasated 
dye  of at  least  5-ram  diana  in  at  least  two  rats  was  taken  as  the  PCA  titer.  The  original 
hyperimmune serum had a  PCA titer of ~ 1:40,000 since titration of the  1:50 dilution revealed 
a  PCA titer of I:800. The  I:58 d{Iut{on  was passed  through sinai1 affinity columns composed P.  W.  ASKENASE, R.  W.  ROSENSTEIN,  AND W.  PTAK  865 
of Sepharose coupled with either anti-IgE, anti-PCLF, or normal rabbit serum and the PCA 
titer of the material passing through the columns was determined as described above. 
Results 
Immune Cells Release Antigen-binding Factors that Can Transfer an Antigen-specific Immediate 
Hypersensitivity-like Reaction (Fig.  1).  Cultured lymphoid cells from mice immunized 
by contact sensitization with either PCL or OX released supernatant factors that were 
specifically purified and concentrated by hapten affinity chromatography on columns 
coated with homologous hapten; i.e., TNP-BGG-sepharose and OX-BGG-sepharose, 
respectively.  Intravenous  transfer  of  these  factors  (PCLF  and  OXF)  to  normal 
nonimmune mice  resulted  in  the  ability  to  elicit  a  4-h  ear  swelling response  to 
challenge by the  homologous contactant, but not by the other contactant (Fig.  1). 
Thus  PCLF  and  OXF  transferred  the  ability to  elicit  antigen specific  immediate 
hypersensitivity-like reactions. 
PCLF Transfers an  Immediate Hypersensitivity Reaction Like IgE,  but Does Not  Compete 
with IgE in a Radioimmunoassay (Figs. 2, 3, and 4).  The kinetics of ear swelling responses 
were similar after PCL challenge of mice that received either PCLF or IgE (Fig. 2). 
Both  responses were evident within 30  min, peaked at  2-4 h,  and rapidly declined 
thereafter (Fig. 2). Also, both responses were accompanied by significantly increased 
vascular permeability (Fig. 3).  Despite the  fact  that  PCLF could passively sensitize 
mice for elicitation of skin reactions of similar kinetics and vascular permeability as 
occurred in reactions mediated by IgE, there was no ability of PCLF to compete with 
125I-labeled IgE  for  binding to  specific rabbit anti-mouse IgE  (Fig.  4).  In contrast, 
three  different  IgE  hybridoma antibodies were  strongly  inhibitory (Fig.  4).  Thus, 
SPECIFICITY  OF  EAR SWELLING  RESPONSES 
IN  RECIPIENTS  OF PCLF  OR  OXF 
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FIG.  1.  Specificity of ear swelling responses in mice receiving PCLF or OXF. Lymph node and 
spleen cells from mice contact sensitized with PCL or OX were cultured for 48 h and supernatants 
were applied respectively to TNP-BGG or OX-BGG-Sepharose and PCLF and OXF eluted (see 
Materials and Methods). Separate groups of five CBA/J mice were injected intravenously with 75 
~g PCLF or OXF. Immediately thereafter mice were challenged on the right ear with 0.8% PCL in 
olive oil and on the left ear with 0.8% OX. Ear swelling  responses  were measured with a micrometer. 
Five noninjected controls were challenged similarly and their resulting ear swelling  response to PCL 
and OX was subtracted from the responses of the mice that were injected intravenously. 866  T CELL-PRODUCED ANTIGEN-BINDING FACTOR ANALOGOUS TO  IgE 
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FIc.  2.  Time course of ear swelling response  in mice receiving PCLF or IgE. Separate groups  of 
male CBA/J mice were injected intravenously with 75 #g PCLF (A) or with 25-75 #g IgE antibody 
(O). Immediately thereafter mice were challenged on both ears with 0.8% PCL in olive oil and then 
ear swelling responses  were measured  with  a  micrometer.  Shown  is  the  time course  of the  ear 
swelling response  measured with a micrometer in  1  l different  experiments that used nine different 
PCLF preparations  in three to six mice per group, and  5 different  experiments that  used  IgE in 
three to six mice per group.  In each experiment a  group of noninjected controls  was challenged 
similarly and their resulting ear swelling response at each time point (Fig. i in re£ 7) was subtracted 
from the response of the mice that were injected  intravenously.  The total number of mice used to 
calculate the mean +  SE is given in parenthesis  at each time point. 
PCLF  had  biologic activity analogous  to  IgE but  had  no e  antigenic determinants  as 
detected by this sensitive competitive binding  radioimmunoassay. 
Passive  Sensitization  with  PCLF is  of Brief Duration  Compared with  IgE  (Fig.  5).  A 
biologic  characteristic  of IgE  is  prolonged  passive  sensitization.  Experiments  were 
performed  to compare  PCLF  with  IgE antibody  for duration  of passive sensitization. 
A  reduced  dose  of IgE  (6  #g)  was  transferred  to  produce  immediate  ear  swelling 
responses equivalent to recipients of PCLF, when both groups were challenged within 
30 min of transfer.  Fig. 5 shows that equivalent ear swelling responses could be elicited 
in recipients of IgE either 0.5 or 48 h  after intravenous transfer. In contrast, equivalent 
ear swelling responses  were elicited in recipients of PCLF  that  were challenged at 0.5 
h,  but  no  response  was  elicited 48  h  after  intravenous  transfer.  Thus,  IgE  mediated 
prolonged  passive sensitization,  whereas passive sensitization with PCLF  was of brief 
duration. 
Affinity Columns Conjugated with Specific Antibodies Show that PCLF and lgE Are Distinct 
Entities  (Fig.  6).  PCLF  transferred  reactions  that  resemble  those  mediated  by  IgE, 
but  no  ~  heavy  chain  determinants  were  detected  in  PCLF  using  either  a  direct- 
binding ELISA  (7)  or a  competitive-binding radioimmunoassay  (Fig. 4).  Experiments 
with specific affinity columns were performed  to further  rule out  the possibility that 
IgE-type  molecules  were  responsible  for  the  biologic  activity  of  PCLF.  Affinity P.  W.  ASKENASE,  R.  W.  ROSENSTEIN,  AND  W.  PTAK 
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FIG.  3.  Ear  swelling and  increased  vascular permeability responses occur  in  recipients of IgE 
antibody or  PCLF.  Separate groups of four mice were  injected intravenously with  75 /~g IgE or 
PCLF or nothing and also received, intravenously, 12SI-bovine serum albumin. Immediately there- 
after mice were challenged on  both ears with 0.8%  PCL and 4 h  later ear swelling responses were 
measured with a micrometer. Ears were then excised and radioactivity was quantitated in a gamma 
counter. 
columns consisted of Sepharose conjugated with rabbit anti-IgE or rabbit anti-PCLF. 
Fig. 6 shows that PCLF activity passed through the anti-IgE column, which retained 
IgE activity and from which IgE activity could be eluted. In contrast, PCLF was not 
retained by the anti-IgE column but was retained  by, and could be eluted from, the 
anti-PCLF column. 
The anti-IgE linked to the affinity column was induced by immunization of rabbits 
with the anti-DNP IgE hybridoma antibody that was used for the transfers (8). In the 
competitive  binding  radioimmunoassay,  anti-IgE  bound  this  IgE better  than  two 
other IgE hybridoma molecules (Fig.  4).  Thus, it was possible that the ability of the 
anti-IgE column to remove hybridoma IgE activity was due to binding of a particular 
IgE clonotype, and thus was possibly due to antiidiotype or anti-IgE subclass activity. 
In  addition,  the  ability  of the  anti-PCLF  column  to  remove  PCLF  and  not  IgE 
hybridoma  activity  could  be  due  to  an  IgE  subclass  specificity.  To  rule  this  out, 
diluted hyperimmune antisera containing polyclonal IgE antibody with a  PCA titer 
of  1:800  was  passed  through  the  anti-IgE  and  anti-PCLF  affinity  columns  and  a 
column  coated  with  normal  rabbit  serum.  Passage  through  the  anti-IgE  column 
removed  all  detectable  PCA  activity,  whereas  passage  through  the  anti-PCLF  or 
normal rabbit serum columns did not affect the PCA titer  (data not shown). Thus, 
polyclonal  IgE activity was removed  by the  anti-IgE affinity column  and  was  not 
removed by the anti-PCLF column. 
Neither PCLF nor IgE Can Passively Sensitize Mast  Cell-deficient Mice  (Fig.  7).  The 
ability  of IgE to  passively sensitize  for elicitation  of immediate  hypersensitivity  is 
dependent  on its ability to bind to skin mast cells. Two different kinds of mast cell 
deficient mice were used to test whether the biologic activity of PCLF was also mast 
cell dependent.  W/W v mice have a  defect  in  bone marrow precursors of skin  mast 
cells and SI/SI  a mice have normal bone marrow precursors of skin mast cells, but lack 
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F1G, 4.  Competitive binding radioimmunoassay of antigenic determinants in IgE. The IgG fraction 
(1:1,000  dilution) of rabbit anti-IgE hybridoma antibody (H 1 DNP-¢-26)  was coated onto wells of 
polystyrene  microtrays.  Then  hapten  affinity-purified  12'~] IgE  (H1  DNP-E-26)  was  mixed  with 
increasing concentrations of either PCLF  (A)  (one preparation is shown, but two different  prepa- 
rations were assayed and gave similar results), the IgE (t tl  DNP-¢-26)  (O) that was used to induce 
the anti-IgE, or another anti-DNP hybridoma IgE (SPE-7  IF) ([~). After incubation and washing, 
separate duplicate wells were cut out, placed in tubes for counting in a gamma counter, and counts 
bound were compared with counts added per well. A third hybridoma lgE antibody with ovalbumin 
specificity (10) was also assayed and gave results similar to IgE SPE-7-IF (results not shown). 
DURATION OF  SENSITIZATION FOR  ELICITATION 
OF CONTACT  EAR  SWELLING RESPONSES 
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F~c.  5.  Passive sensitization with PCLF is of brief duration compared with IgE. Separate groups 
of four mice were injected intravenously with 6 #g IgE or 100 #g PCLF.  30 min or 48 h later mice 
were challenged on both ears with 0.8%  PCL, and 2 h  later ear swelling responses were measured 
with a micrometer. A group of noninjected controls was challenged similarly and their resulting ear 
swelling response was subtracted from the response of the mice that were injected intravenously. 
into  mature  mast  cells  (20-23).  Both  strains  have  <--1% the  numbers  of cutaneous 
mast cells compared with their  appropriate  +/+  controls  (20-23).  Fig.  7 shows that 
PCLF,  like  IgE, was  unable  to passively  sensitize  either  type of mast  cell-deficient P.  W.  ASKENASE,  R.  W.  ROSENSTEIN,  AND  W.  PTAK  869 
AFFINITY  COLUMNS AND TRANSFER  OF  EAR  SWELLING  RESPONSES 
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F~o.  6.  Affinity column separation of ]gE vs. PCLF activity that transfers the ability to elicit ear 
swelling responses. Two aliquots of IgE or  PCLF were each applied  to affinity columns coupled 
with  anti-lgE  or  anti-PCLF.  After  the  material  passing through the  columns  (the  filtrate)  was 
collected,  and the columns were washed thoroughly, material bound to the columns (the eluate) 
was obtained by passing 0.2 M  Na2CO3 through the columns. After dialysis the filtrate and eluate 
were injected intravenously into separate groups of mice that were challenged immediately thereafter 
with 0.8%  PCL  4  h  later ear swelling responses were  measured with a  micrometer.  A  group of 
noninjected controls was challenged similarly and their  resulting ear swelling response was sub- 
tracted from the response of the mice that were injected intravenously. 
mouse for elicitation of immediate hypersensitivity-like responses compared to +/+ 
littermates. Thus, the biologic activity of PCLF, like IgE, is mast cell dependent. 
Discussion 
We have shown that PCLF, a  T  cell-derived antigen-binding factor, has many in 
viva  functional  characteristics  analogous  to  IgE  antibody.  Both  mediate  antigen- 
specific skin swelling responses that  are evident within  30 rain and peak between  2 
and 4 h  after local challenge.  Both responses are accompanied by increased vascular 
permeability and, importantly, neither the T  cell factor nor IgE can passively sensitize 
mast  cell-deficient  mice.  The  fact  that  neither  IgE  nor  PCLF  was  active  in  two 
mutant strains of mice with completely different defects that each lead to mast cell 
deficiency  makes  it  unlikely  that  another  associated  defect  not  pertaining  to  mast 
cells was responsible for the  inability  of either strain  to serve as suitable recipients. 
This  argues  that  the  mechanism  of action  of PCLF,  like  that  of IgE,  is  mast  cell 
dependent.  Moreover, morphologic evidence of mast cell activation occurs at sites of 
skin reactions that are mediated by PCLF (S, Kraeuter-Kops, H. Van Loveren, R. W. 
Rosenstein, W. Ptak, and P. W. Askenase, unpublished results). 
Intravenous  administration  of IgE  passively  sensitized  recipients  for  prolonged 
reactivity, whereas similarly administered PCLF was only able to passively sensitize 870  T CELL-PRODUCED ANTIGEN-BINDING FACTOR  ANALOGOUS TO  IgE 
CONTACT  EAR  SWELLING  RESPONSES  IN MAST CELL  DEFICIENT  MICE 
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FIo.  7.  Neither lgE nor PCLF transfers the ability to elicit ear swelling responses m mast cell 
deficient mice. Separate groups of mast cell deficient mice of two types (W/W  V  and SI/SIa), and 
their appropriate +/+ controls,  were injected intravenously  with 33 #g IgE, 75/~g PCLF, or nothing 
(12 mice of each type were used at 4 per group). Immediately thereafter mice were challenged on 
both ear's with 0.8% PCL, and 4 h later ear swelling responses were measured with a micrometer. 
Ear swelling responses in noninjected mast cell deficient mice of both types and their appropriate 
+/+ controls were subtracted from the ear swelling response of the corresponding mice that were 
injected intravenoulsy. 
recipients for  a  short  time.  Prolonged sensitization is expected  with  IgE  antibody. 
This is a manifestation of the unique ability of its Fc portion to bind with high affinity 
to specialized Fc receptors on the surface of skin mast cells. The simplest explanation 
of our findings is that PCLF passively sensitizes mast cells for a short time. However, 
we have not yet been able to demonstrate that PCLF can passively sensitize mast cells 
directly, using either PCA reactions in vivo, or release of serotonin from murine mast 
cell suspensions in vitro.  Since the  IgE  hybridoma antibody is  very active in both 
assays, this suggests that the mechanism of mast cell activation by PCLF is different 
than the mechanism of mast cell activation by IgE. 
The active moiety in PCLF has a  molecular weight of 70,000 or less (7), is derived 
from lymphoid cells depleted of B  cells (7), has no Ig heavy or light chain antigenic 
determinants (7), and has antigenic determinants found on T  cells and on antigen- 
specific T  cell factors (7,  14-16). Despite these findings indicating that PCLF is T  cell 
derived and not an Ig, the striking resemblence between the biologic activity of PCLF 
and IgE necessitated rigorous experiments to rule out the possibility that  the active 
moiety in PCLF was due to contamination with IgE or that PCLF was a  fragment or 
a  potential  subclass  of  IgE  (24).  These  studies  showed  that  no  E  heavy  chain 
determinants were  found  in  PCLF,  using either  a  direct-binding ELISA  (7)  or  a 
competitive  binding  radioimmunoassay  (Fig.  4).  Affinity  chromatography  using P.  w.  ASKENASE, R. W.  ROSENSTEIN, AND W.  PTAK  871 
specific  anti-IgE  and  anti-PCLF  antibodies  linked  to  Sepharose  showed  complete 
separation of the ability of IgE and the active moiety in PCLF to passively sensitize 
for elicitation of immediate ear swelling responses. We ruled out the possibility that 
the particular  anti-IgE column we used could  fail to bind some IgE clonotypes, or 
that the anti-PCLF column could bind an IgE subclass. This was done by applying 
a hyperimmune polyclonal IgE antibody activity (as measured by PCA titrations)  to 
the anti-IgE and anti-PCLF affinity columns.  Thus PCLF,  despite the fact that  its 
biologic activity resembles that of IgE, is a  T  cell factor that is clearly distinct  from 
IgE antibody. 
The impetus for this work was the finding that T  cell-dependent activation of mast 
cells is required  for elicitation  of delayed-type hypersensitivity responses  (3-6).  The 
finding of T  cell-derived antigen-binding factors that resemble the in vivo activity of 
IgE antibody  provides  a  mechanism  by which  T  cell  activation of mast cells  may 
occur in cell-mediated immunity. This finding also raises the possibility that similar 
T  cell-dependent mechanisms may underly immediate hypersensitivity-like responses 
in  which  appropriate  IgE antibodies  have  not  been  found,  such  as  some  types of 
asthma, rhinitis, urticaria, or food allergy. T  cell factors that can mediate immediate 
mast  cell-dependent  responses  that  feature  increased  vascular  permeability  could 
participate in some of these conditions. 
Summary 
T cell-dependent activation of resident tissue mast cells is required for the elicitation 
of delayed-type  hypersensitivity  skin  reactions  in  mice.  A  T  cell-derived  antigen- 
binding  factor that  transfers  the  ability to elicit  an  immediate hypersensitivity-like 
skin reaction is described and compared with a hybridoma IgE antibody. Both the T 
cell factor and IgE mediate reactions with increased vascular permeability and both 
are  mast  cell  dependent,  as  they  are  inactive  in  two  different  types  of mast  cell 
deficient mice (W/W V and S1/Sld). The T  cell factor was distinguished  from IgE by 
affinity chromatography using specific anti-IgE and anti-factor antibodies and by a 
shorter duration of passive sensitization. The T  cell factor is a  suitable candidate for 
participation in the mechanism by which T  cells activate mast cells in delayed-type 
hypersensitivity. 
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